August 6, 2025 — Ventric Health Announces New Study on Heart Failure Diagnosis
Ventric Health, a leading medtech firm dedicated to advancing early diagnosis of heart failure (HF) within primary care settings, has announced the publication of a new study. The research demonstrates that the company's Vivio System, when combined with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), effectively identifies patients with previously undiagnosed HF who may benefit from further treatment. The findings are featured in the latest issue of JACC: Advances.
Current Challenges in Heart Failure Diagnosis
Currently, most HF diagnoses occur during emergency room visits or hospital stays, often when symptoms are severe, indicating advanced disease and diminished quality of life. The standard diagnostic measure—elevated left ventricular end-diastolic pressure (LVEDP)—traditionally requires invasive, in-hospital catheterization, which limits accessibility.
Vivier System Facilitates Early Detection
The FDA-approved Vivio System facilitates earlier detection by providing a quick, non-invasive measurement of LVEDP during a typical primary care visit, taking on...